Medical Alley, MN – The Medical Alley Association (MAA) is pleased to announce Takeda Pharmaceutical Company Limited (“Takeda”) as its newest foundational member.
“Takeda is a vital member of the Medical Alley community,” said MAA Interim President and CEO Steffen Hovard. “They have significantly invested in our region, and we’re thrilled to welcome them further into our organization as a foundational member.”
Takeda is an important innovator in Minnesota’s Medical Alley. The company has invested in the region through the construction of a $75 million manufacturing facility in Brooklyn Park and the creation of seven BioLife Plasma Services collection centers throughout the state.
Takeda has also contributed significantly to Minnesota’s economy by providing highly-skilled manufacturing jobs, workforce development and training opportunities, and producing life-transforming treatments. The company employs more than 750 people in Minnesota, making it one of the state’s largest biotech manufacturing employers.
“The Medical Alley Association is an incredible partner for Takeda and the entire biotechnology industry, and we’re looking forward to deepening our relationship with the organization as a foundational member,” said Matt Kenning, Site Head of Takeda’s Brooklyn Park facility.
Takeda joins a unique and impressive group of companies at the foundational membership level from every sector of healthcare. Together, they are working to transform the future of the healthcare industry.
About The Medical Alley Association
Founded in 1984, MAA supports and advances the global leadership of Medical Alley’s healthcare industry, and its connectivity around the world. MAA delivers the collective influence, intelligence, and interactions that support Medical Alley.